NCT06752616View on ClinicalTrials.gov

Acute Agitation in Emergency Psychiatry

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

December 30, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Agitation
Interventions
DRUG

Sublingual Dexmedetomidine

Sublingual dexmedetomidine 180 mcg, possible second dose 90 mcg after 2 hrs

DRUG

Buccal midazolam

Buccal midazolam 10 mg, possible second dose 10 mg after 2 hrs

DRUG

Oral lorazepam

Oral lorazepam 4 mg, possible second dose 4 mg after 2 hrs

Trial Locations (1)

2400

RECRUITING

Mental Health Center Copenhagen, Bispebjerg, Copenhagen N

All Listed Sponsors
collaborator

Copenhagen University Hospital - Bispebjerg and Frederiksberg Hospital

UNKNOWN

collaborator

Capital Region's Pharmacy (Region Hovedstadens Apotek), Marielundvej 25, 2730 Herlev, Denmark

UNKNOWN

lead

Lone Baandrup

OTHER